Sex disparities in DNA damage response pathways: Novel determinants in cancer formation and therapy.

Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE

Original Publication: [Cambridge, MA] : Cell Press, [2018]-

Cancer incidence and survival are different between men and women. Indeed, females have a lesser risk and a better prognosis than males in many tumors unrelated to reproductive functions. Although the reasons for these disparities are still unknown, they constitute an important starting point for the development of personalized cancer therapies. One of the mechanisms that fuels carcinogenesis is the accumulation of defects in DNA damage response (DDR) pathways, a complex signaling cascade that senses DNA lesions and, depending on the severity, coordinates transient cell-cycle arrest, DNA replication, repair, apoptosis, and senescence, preventing genomic instability and cancer. Recently, evidence of sexual dimorphisms is emerging in these pathways, therefore providing new opportunities for precision medicine. Here, we will discuss current knowledge about sexual disparities in the DDR, their role in tumorigenesis and cancer progression, and the importance of considering sex contribution in both research and cancer therapies.
Competing Interests: The authors declare no competing interest
(© 2022 The Author(s).)

J Pediatr. 2011 Feb;158(2):215-20. (PMID: 20855079)
Int J Mol Sci. 2020 Sep 09;21(18):. (PMID: 32917005)
PLoS One. 2012;7(3):e33867. (PMID: 22439007)
Physiol Rep. 2017 Mar;5(6):. (PMID: 28325789)
Breast Cancer Res. 2008;10(3):R43. (PMID: 18471300)
Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1614-8. (PMID: 8434025)
Mol Cell. 2016 Mar 3;61(5):667-676. (PMID: 26942671)
Mech Ageing Dev. 2008 Jul-Aug;129(7-8):383-90. (PMID: 18417187)
Clin Sci (Lond). 2017 May 1;131(9):803-822. (PMID: 28424375)
Front Oncol. 2019 Jul 17;9:635. (PMID: 31380275)
Cancer Res. 2006 Aug 15;66(16):8287-92. (PMID: 16912210)
Cancer Cell. 2016 May 9;29(5):711-722. (PMID: 27165743)
Nat Rev Cancer. 2015 Mar;15(3):166-80. (PMID: 25709118)
Cancer Cell. 2010 Jan 19;17(1):98-110. (PMID: 20129251)
Aging Cell. 2011 Dec;10(6):913-21. (PMID: 21902801)
Cell. 2004 Nov 24;119(5):591-602. (PMID: 15550242)
Free Radic Biol Med. 2009 Jan 15;46(2):169-75. (PMID: 18992805)
Cells. 2020 Jul 10;9(7):. (PMID: 32664329)
N Engl J Med. 2004 Mar 4;350(10):991-1004. (PMID: 14999111)
Toxicol Lett. 2004 Jun 15;151(1):113-34. (PMID: 15177647)
Sci Adv. 2018 Jun 13;4(6):eaar5598. (PMID: 29928692)
Mol Biol Rep. 2013 Sep;40(9):5261-73. (PMID: 23673479)
Free Radic Biol Med. 2008 Dec 15;45(12):1631-41. (PMID: 18845243)
Nat Rev Mol Cell Biol. 2019 Apr;20(4):199-210. (PMID: 30824861)
CA Cancer J Clin. 2021 May;71(3):209-249. (PMID: 33538338)
Proc Natl Acad Sci U S A. 2009 Oct 6;106(40):17111-6. (PMID: 19805189)
Cytogenet Genome Res. 2006;112(3-4):194-201. (PMID: 16484772)
Nat Commun. 2020 May 6;11(1):2219. (PMID: 32376827)
Nat Rev Mol Cell Biol. 2013 May;14(5):297-306. (PMID: 23594950)
Annu Rev Pathol. 2016 May 23;11:617-44. (PMID: 27022975)
Exp Gerontol. 2014 Mar;51:15-27. (PMID: 24365661)
Cancer Res. 2003 Oct 15;63(20):6643-50. (PMID: 14583457)
Sci Transl Med. 2019 Jan 2;11(473):. (PMID: 30602536)
Cell Mol Gastroenterol Hepatol. 2018 Sep 14;7(1):93-113. (PMID: 30510993)
Eur J Cancer. 2019 Nov;121:40-47. (PMID: 31542640)
Adv Cancer Res. 2010;108:73-112. (PMID: 21034966)
J Thorac Oncol. 2010 May;5(5):640-8. (PMID: 20354457)
Cancer Res. 2015 Jul 1;75(13):2686-98. (PMID: 25977336)
Oncogene. 2016 May 5;35(18):2322-32. (PMID: 26257066)
Radiat Oncol. 2019 May 2;14(1):74. (PMID: 31046792)
DNA Repair (Amst). 2018 Nov;71:177-182. (PMID: 30177435)
Proc Biol Sci. 2007 Mar 22;274(1611):819-25. (PMID: 17251089)
J Mol Cell Biol. 2014 Dec;6(6):442-57. (PMID: 25404613)
J Clin Invest. 2019 May 1;129(5):1818-1826. (PMID: 31042159)
Pediatrics. 2016 Apr;137(4):. (PMID: 26969272)
Nat Rev Immunol. 2016 Oct;16(10):626-38. (PMID: 27546235)
Nat Commun. 2016 Aug 12;7:12157. (PMID: 27515585)
J Clin Oncol. 2009 Mar 10;27(8):1250-6. (PMID: 19204208)
BMC Cancer. 2021 Mar 7;21(1):240. (PMID: 33678158)
Antioxid Redox Signal. 2020 Oct 20;33(12):839-859. (PMID: 32151151)
Int J Mol Sci. 2020 Nov 04;21(21):. (PMID: 33158305)
J Clin Invest. 2014 Sep;124(9):4123-33. (PMID: 25083989)
J Intern Med. 2008 Mar;263(3):302-12. (PMID: 18070000)
Nat Rev Cancer. 2016 May;16(5):330-9. (PMID: 27079803)
Front Cell Dev Biol. 2021 May 12;9:669379. (PMID: 34055802)
J Radiat Res. 2016 Aug;57 Suppl 1:i11-i17. (PMID: 27068998)
Aging (Albany NY). 2014 Jun;6(6):432-9. (PMID: 25140379)
Cancer Lett. 2018 Apr 10;419:280-290. (PMID: 29378238)
Nucleic Acids Res. 2015 May 26;43(10):4893-908. (PMID: 25934801)
Nat Commun. 2019 Nov 26;10(1):5385. (PMID: 31772231)
Cancer Epidemiol Biomarkers Prev. 2003 Aug;12(8):689-98. (PMID: 12917198)
Sci Rep. 2016 Apr 22;6:24955. (PMID: 27102014)
Front Oncol. 2013 Nov 27;3:290. (PMID: 24350055)
Br J Ophthalmol. 2009 Jan;93(1):24-7. (PMID: 18718969)
Int J Biol Sci. 2015 Jul 03;11(9):992-1005. (PMID: 26221067)
FEBS J. 2013 Jul;280(14):3180-93. (PMID: 23647631)
Oncogenesis. 2020 Mar 13;9(3):35. (PMID: 32170104)
Pediatr Blood Cancer. 2019 Jun;66(6):e27620. (PMID: 30815990)
Gastroenterology. 2008 Sep;135(3):947-55, 955.e1-5. (PMID: 18639551)
Neuropathol Appl Neurobiol. 2013 Apr;39(3):298-315. (PMID: 22639898)
Nat Rev Cancer. 2020 Aug;20(8):471-480. (PMID: 32404993)
DNA Repair (Amst). 2020 Nov;95:102948. (PMID: 32866776)
Cancer Cell. 2015 Jul 13;28(1):97-113. (PMID: 26175416)
JAMA. 2004 Jun 9;291(22):2720-6. (PMID: 15187053)
Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16633-8. (PMID: 17921246)
Biol Sex Differ. 2020 Apr 15;11(1):17. (PMID: 32295632)
Aging Cell. 2013 Feb;12(1):58-66. (PMID: 23088435)
Acta Neuropathol Commun. 2018 Feb 20;6(1):12. (PMID: 29458417)
Ann Oncol. 2019 Dec 1;30(12):1914-1924. (PMID: 31613312)
Nature. 2009 Dec 17;462(7275):935-9. (PMID: 20016603)
Pathol Res Pract. 2019 Sep;215(9):152538. (PMID: 31326197)
J Natl Cancer Inst. 2000 Nov 1;92(21):1764-72. (PMID: 11058619)

Keywords: Cancer; Cell biology; Cellular physiology

Date Created: 20220304 Latest Revision: 20220305

20221213

PMC8858993

10.1016/j.isci.2022.103875

35243237